Prenatal testing for hereditary predisposition to mammary and ovarian carcinoma - Defining a position;Prenatale diagnostiek naar de erfelijke aanleg voor mamma-/ovariumcarcinoom - Een standpuntbepaling

Nederlands Tijdschrift voor Geneeskunde

Volumn 146, Issue 31, 2002, Pages 1461-1465

  Cobben, J M ^a   Brocker Vriends A H J T ^a   Leschot, N J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER SUSCEPTIBILITY; GENE MUTATION; GENETIC PREDISPOSITION; HEALTH CARE POLICY; HETEROZYGOTE; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; ONCOGENE; OVARY CARCINOMA; PARENT COUNSELING; PRENATAL DIAGNOSIS; ABORTION; BREAST TUMOR; ETHICS; FEMALE; GENETIC COUNSELING; GENETIC SCREENING; GENETICS; MUTATION; ONCOLOGY; OVARY TUMOR; PREGNANCY; PSYCHOLOGICAL ASPECT; TUMOR SUPPRESSOR GENE;

ABORTION, EUGENIC; BREAST NEOPLASMS; ENGLISH ABSTRACT; ETHICS, CLINICAL; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMAN; MEDICAL ONCOLOGY; MUTATION; OVARIAN NEOPLASMS; PREGNANCY; PRENATAL DIAGNOSIS; HUMANS;

EID: 0037014823     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Breast and ovarian cancer incidence in BRCA1-mutation carriers
2. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families
3. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families
4. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews
5. Breast cancer genes - What are the real risks?
6. Risks of cancer in BRCA1-mutation carriers
7. Cancer risks in BRCA2 mutation carriers
8. Vrouwen met erfelijk risico op borstkanker: Consensus van chirurgische vertegenwoordigers van de werkgroepen voor erfelijke tumoren ten aanzien van intensieve controle, diagnostiek en preventieve ablatio
9. Benefit of mammography screening in women ages 40 to 49 years. Current evidence from randomized controlled trials
10. Is there a place for screening in ovarian cancer?
11. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer
12. Prophylactic mastectomy - The price of fear
13. Primary breast cancer after prophylactic mastectomy
14. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation
15. Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry
16. Genetic susceptibility testing and prophylactic oophorectomy
17. Genetic testing for BRCA1 and BRCA2: Recommendations of the Stanford Program in Genomics, Ethics, and Society
18. Organisatie en beleid van prenatale diagnostiek in Nederland
19. Erfelijke borstkanker en prenatale diagnostiek
20. Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands
21. Prenatal testing for Huntington's disease: Experience within the UK 1994-1998
22. An inevitable dilemma: Prenatal testing for mutations in the BRCA1 breast-ovarian cancer susceptibility gene
23. Prenatal testing for late-onset diseases such as mutations in the breast cancer gene I (BRCA1). Just a choice or a step in the wrong direction?